BioSpace News Archive

Genome Editing Market Size ($16.98Bn by 2028) Lead by CRISPR Technology (18.4% CAGR) - Exclusive Research Report by The Insight Partners

According to our new research study on “Genome Editing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (CRISPR, TALEN, Antisense, and Others)

June 1, 2023
·
6 min read
$4.01Bn by 2028, Pharmaceutical Fill and Finish Outsourcing Market Size, 6.1% CAGR Lead by Biopharmaceutical Industry and Biologics - Exclusive Research Report by The Insight Partners

According to our new research study on “Pharmaceutical Fill and Finish Outsourcing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By State of Finished Products

June 1, 2023
·
5 min read
3D Printing Medical Devices Market (Component, Technology) Size, $6,583.50 Million by 2028 Lead by Software and Services, 17.5% CAGR - Exclusive Research Report by The Insight Partners

According to our new research study on “3D Printing Medical Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Component [Software and Services

June 1, 2023
·
6 min read
AB Science announces issuance of a Canadian patent for masitinib in the treatment of ALS with protection until 2037

AB Science SA (Euronext - FR0010557264 - AB) today announced that the patent office of Canada has issued a Notice of Allowance (NOA) for a patent relating to methods of treating amyotrophic lateral sclerosis (ALS) with its lead compound masitinib (CA 3018635).

June 1, 2023
·
4 min read
Biotech Beach

Navigate BioPharma Services, Inc. launches new multiplex digital PCR assay for comprehensive quantification of up to 5 different CAR-T transgenes

During this year’s AAPS National biotechnology conference, Navigate BioPharma Services, Inc. announced the launch of its new multiplex digital PCR assays for comprehensive quantification of multiple chimeric antigen receptor (CAR) T cells, a type of cancer immunotherapy that involves genetically modifying T cells to recognize and destroy certain cancers.

June 1, 2023
·
2 min read
Drug Development

Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment

Sirnaomics Ltd. (the “Company"; together with its subsidiaries, the “Group” or “Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced it has dosed the first participant in a Phase I clinical trial of STP122G for anticoagulation treatment.

June 1, 2023
·
4 min read
Biotech Beach

TORL BioTherapeutics Announces Initial Results of Novel Claudin 6 (CLDN6) Targeted Antibody Drug Conjugate (ADC) TORL-1-23 Selected for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

TORL BioTherapeutics LLC announces the initial results from an ongoing phase I study of their claudin 6 targeted antibody drug conjugate, TORL-1-23, in patients with advanced cancer on the American Society of Oncology website.

June 1, 2023
·
4 min read
Biotech Bay

Scilex Holding Company provides certain preliminary unaudited financial results for gross and net Sales for the one month ended May 2023, and year-to-date May 2023, based on currently available information

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. is providing certain preliminary unaudited financial results for the month ended May 31, 2023, and year-to-date as of May 31, 2023, based on currently available information.

June 1, 2023
·
7 min read
Biotech Beach

CureScience™ Institute Publishes A Review Article on Neoantigens

CureScience™ Institute is pleased to announce the publication of “Designing neoantigen cancer vaccines, trials, and outcomes” by Biswas, N., Chakrabarti, S., Padul, V., Jones, L. D., & Ashili, S.

June 1, 2023
·
2 min read
Pharm Country

Feinstein Institutes bioelectronic medicine researchers stimulate vagus nerve to reduce bleeding in hemophilia

Hemophilia A, a bleeding disorder that prevents blood from clotting, affects more than 30,000 people in the United States and, in high-risk situations, can lead to death.

June 1, 2023
·
5 min read